These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17948276)

  • 1. Non-remission of depression in the general population as assessed by the HAMD-7 scale.
    Bulloch AG; Patten SB
    Depress Anxiety; 2008; 25(5):393-7. PubMed ID: 17948276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL; Evans KR; Sills TL; Kalali AH
    Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring depressive symptoms in the naturalistic primary-care setting.
    McIntyre RS; Konarski JZ; Kennedy SH; Dickens SE; Bagby RM
    Int J Clin Pract; 2007 Aug; 61(8):1278-82. PubMed ID: 17590219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaco-epidemiologic study of the use of antidepressant drugs in the general population].
    Rouillon F; Blachier C; Dreyfus JP; Bouhassira M; Allicar MP
    Encephale; 1996 May; 22 Spec No 1():39-48. PubMed ID: 8767026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
    Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective: remission of depression in primary care The Oreon Study.
    Ansseau M; Demyttenaere K; Heyrman J; Migeotte A; Leyman S; Mignon A
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):169-76. PubMed ID: 19144502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major depression: prevalence, treatment utilization and age in Canada.
    Patten SB; Sedmak B; Russell ML
    Can J Clin Pharmacol; 2001; 8(3):133-8. PubMed ID: 11574895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of dialectical behavior therapy skills training group for treatment-resistant depression.
    Harley R; Sprich S; Safren S; Jacobo M; Fava M
    J Nerv Ment Dis; 2008 Feb; 196(2):136-43. PubMed ID: 18277222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating antidepressant therapies: remission as the optimal outcome.
    Thase ME
    J Clin Psychiatry; 2003; 64 Suppl 13():18-25. PubMed ID: 14552652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
    Darbinyan V; Aslanyan G; Amroyan E; Gabrielyan E; Malmström C; Panossian A
    Nord J Psychiatry; 2007; 61(5):343-8. PubMed ID: 17990195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.
    Suzuki Y; Fukui N; Sawamura K; Sugai T; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T
    J Clin Psychopharmacol; 2008 Jun; 28(3):325-8. PubMed ID: 18480690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant treatment of depression in rural nursing home residents.
    Kerber CS; Dyck MJ; Culp KR; Buckwalter K
    Issues Ment Health Nurs; 2008 Sep; 29(9):959-73. PubMed ID: 18770101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes to depression and its treatment in primary care.
    Weich S; Morgan L; King M; Nazareth I
    Psychol Med; 2007 Sep; 37(9):1239-48. PubMed ID: 17559705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial remission indicates poor functioning and a high level of psychiatric symptoms: a 3-phase 6-year follow-up study on major depression.
    Viinamäki H; Hintikka J; Tolmunen T; Honkalampi K; Haatainen K; Koivumaa-Honkanen H
    Nord J Psychiatry; 2008; 62(6):437-43. PubMed ID: 18836926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid chronic diseases in depressed and non-depressed patients in family practice.
    Diminić-Lisica I; Francisković T; Janović S; Popović B; Klarić M; Nemcić-Moro I
    Psychiatr Danub; 2010 Jun; 22(2):236-40. PubMed ID: 20562753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to guidelines and effectiveness of inpatient treatment for unipolar depression.
    Köhler S; Hoffmann S; Unger T; Steinacher B; Fydrich T
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):103-12. PubMed ID: 22141401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.